Article

lock Open Access lock Peer-Reviewed

26

Views

ARTIGO ORIGINAL

Síndrome vasoplégica: nova forma de síndrome pós perfusão

Walter José GomesI; Marcelo Grandini SilasI; Marly Garcia LopesI; José Honório PalmaI; Carlos Alberto TelesI; João Nelson R BrancoI; Antônio Carlos CarvalhoII; Ênio BuffoloI

DOI: 10.1590/S0102-76381996000100008

Texto completo disponível apenas em PDF.

REFERÊNCIAS

1. ALLARDYCE, D. B.; YOSHIDA, S. H.; ASHMORE, P. G. - The importance of microembolism in the pathogenesis of organ disfunction caused by prolonged use of pump oxygenator. J. Thorac. Cardiovasc. Surg., 52: 706-712, 1996.

2. BELLOMO, R. - The cytokine network in the critically ill. Anaesth. Intens. Care, 20: 288-302, 1992.

3. BERNARDI, C. & TEDGUI, A. - Cytokine network and the vessel wall: insights into septic shock pathogenesis. Eur. Cytokine Netw., 3: 19-33, 1992. [MedLine]

4. BUTLER, J.; ROCKER, G. M.; WESTABY, S. - Inflammatory response to cardiopulmonary bypass. Ann. Thorac. Surg., 55: 552-559, 1993. [MedLine]

5. CHENOWETH, D. E.; COOPER, S. W.; HUGLI, T. E.; STEWART, R.; BLACKSTONE, E. H.; KIRKLIN, J. W. - Complement activation during cardiopulmonary bypass: evidence for generation of C3a and C5a anaphylatoxins. N. Engl. J. Med., 304: 497-503, 1981. [MedLine]

6. DOWNING, S. W. & EDMUNDS Jr., L. H. - Release of vasoactive substances during cardiopulmonary bypass. Ann. Thorac. Surg., 54: 1236-1248, 1992.

7. FINN, A.; NAIK, S.; KLEIN, N.; LEVINSKY, R. J.; STROBEL, S.; ELLIOTT, M. - lnterleukin-8 release and neutrophil degranulation after pediatric cardiopulmonary bypass. J. Thorac. Cardiovasc. Surg., 105: 234-241, 1993. [MedLine]

8. FONG, Y.; MOLDAWER, L. L.; SHIMS, G. T.; LOWRY, S. F. - The biological characteristics of cytokines and their implication in surgical injury. Surg. Gynecol. Obstet., 170: 363-378, 1990. [MedLine]

9. GOMES, W. J.; CARVALHO, A. C.; PALMA, J. H.; GONÇALVES, I.; BUFFOLO, E. - Vasoplegic syndrome: a new dilemma. J. Thorac. Cardiovasc. Surg., 107: 942-943, 1994. [MedLine]

10. HENNEIN, H. A.; EBBA, H.; RODRIGUEZ, J. L.; MERRICK, S. H.; KEITH, F. M.; BRONSTEIN, M. H.; LEUNG, J. M.; MANGANO, D. T.; GREENFIELD, L. J.; RANKIN, J. C. - Relationship of the proinflammatory cytokines to myocardial ischemia and dysfunction after uncomplicated coronary revascularization. J. Thorac. Cardiovasc. Surg., 108: 626-635, 1994. [MedLine]

11. JANSEN, N. J. G.; van OEVEREN, W.; GU, Y. J.; van VLIET, M. H.; EIJSMAN, L.; WILDEVUUR, C. R. H. - Endotoxin release and tumor necrosis factor formation during cardiopulmonary bypass. Ann. Thorac. Surg., 54: 744-748, 1992.

12. KIRKLIN, J. K. - The postperfusion syndrome: inflammation and the damaging effects of cardiopulmonary bypass. In: TINKER, J. H. Cardiopulmonary bypass: current concepts and controversies. Philadelphia, W. B. Saunders, 1989, p. 131-146.

13. KIRKLIN, J. K.; WESTABY, S.; BLACKSTONE, E. H.; KIRKLIN, J. W.; PACIFICO, A. D.; CHENOWETH, D. E. - Complement and the damaging effects of cardiopulmonary bypass. J. Thorac. Cardiovasc. Surg., 86: 845-857, 1983. [MedLine]

14. LAMAS, S.; MICHEL, T.; BRENNER, B. M.; MARSDEN, P. A. - Nitric oxidein endothelial cells: evidence for a pathway inducible by TNF-alpha. Am. J. Physiol., 261: C634-C641, 1991. [MedLine]

15. MANTOVANI, A & DEJANA, E. - Cytokines as communication signals between leukocytes and endothelial cells. Immunol. Today, 10: 370-5, 1989. [MedLine]

16. MORRISON, D. C. & RYAN, J. L. - Endotoxins and disease mechanisms. Am. Rev. Med., 38: 417-432, 1987.

17. RIGATO Jr., O - Avaliação dos níveis séricos de fator de necrose de tumor alfa (TNF-a) em pacientes com diagnóstico clínico de sepse. Relevancia da doença de base e associação com evolução. São Paulo, 1993. [Tese. Mestrado. Escola Paulista de Medicina].

18. ROCKE, D. A.; GRAFFIN, S. L.; WELLS, M. T.; KOEN, Y.; BROCK-UTINE, J. G. - Endotoxemia associated with cardiopulmonary bypass, J. Thorac. Cardiovasc. Surg., 93: 832-837, 1987. [MedLine]

19. STARNES Jr., H. F.; WARREN, R. S.; JEEVANANDAM, M. - Tumor necrosis factor and the acute metabolic response to tissue injury in man. J. Clin. Invest., 82: 1321-1325, 1988. [MedLine]

20. WATARIDA, S.; MPRI, A.; ONOE, M.; TABATA, R.; SHIRAISHI, S.; SUGITA, T.; NOJIMA, T.; NAKAJIMA, Y.; MATSUNO, S. - A clinical study on the effects of pulsatile cardiopulmonary bypass on the blood endotoxin levels. J. Thorac. Cardiovasc. Surg., 108: 620-625, 1994. [MedLine]

21. WESTABY, S. - Organ disfunction after cardiopulmonary bypass: a sistemic inflammatory reaction initiated by the extracorporeal circuit. Int. Care Med., 13: 89-95, 1987.

22. YOUNG, L. S. - Endotoxins and mediators: an introduction. In: STURK, A. Bacterial endotoxins: citokine mediators and new therapies for sepsis. New York, Wiley-Liss, 1991, p. 1-7.

CCBY All scientific articles published at bjcvs.org are licensed under a Creative Commons license

Indexes

All rights reserved 2017 / © 2024 Brazilian Society of Cardiovascular Surgery DEVELOPMENT BY